A Seoul, South Korea, research team says it's identified the defense mechanism used by cancer cells to fight therapeutic chemicals.
Team leader Kim Kun-hong of Yonsei University told the Korea Times the discovery that enzyme protein kinase CK2 makes cancer cells resistant to cancer-specific therapeutic chemicals, such as "Trail," is a step toward developing effective treatments for the disease.
Kim said the enzyme influences a protein called procaspase-2 to become phosphate, which keeps the cells from dying and makes them resistant to medication.
However, when Trail was injected in the cancer cells with certain chemical substances the cells became sensitive to Trail and entered the normal death-inducing process.
The researchers tested 31 types of cancer cells and found that by suppressing PKCK2, Trail successfully killed the cancer cells in all the 31 types, regardless of the developmental stage of the cancer cell, Kim told the Korea Times.
The research appears in the online edition of the journal of the European Molecular Biology Organization.
Copyright 2005 by United Press International
Related stories:
On the trail of a targeted therapy for blood cancers
Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults.
Researchers find targeted therapy combination overcomes treatment resistance in liver cancer
Researchers at the University of Pennsylvania School of Medicine and Abramson Cancer Center reported today at the annual meeting of the American Association for Cancer Research that combining two targeted therapies overcomes treatment resistance in liver cancer cell lines. The team is currently designing a trial to test the combination in patients.
Novel strategy under study for aggressive leukemia
A novel strategy to hopefully beat into oblivion one of the most aggressive forms of acute myelogenous leukemia combines the strengths of some of the newest leukemia agents, researchers say.
Laser blasts viruses in blood
A father-son research team working from separate laboratory benches across the country has discovered a new use for lasers - zapping viruses out of blood. The technique, which holds promise for disinfecting blood for transfusions, uses a low-power laser beam with a pulse lasting just fractions of a second.
Penn researchers identify new combination therapy that promotes cancer cell death
Philadelphia -- Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials They propose that the therapy may help to selectively eliminate cancer cells while leaving healthy cells intact, providing a cancer treatment with fewer side effects. The Penn team reports their findings in the July issue of Cancer Cell.
Ancient Genetic Material Keeps Pups Pint-Sized
Soon after humans began domesticating dogs 12,000 to 15,000 years ago, they started breeding small canines. Now, scientists from the University of Utah and seven other institutions have identified a piece of doggy DNA that reduces the activity of a growth gene, ensuring that small breeds stay small.
Researchers hot on the trail of brain cell degeneration
A research team headed by Academy Research Fellow Michael Courtney has identified a new molecular pathway in neurons. The pathway is a factor in the degeneration of brain cells, which in turn plays an important role in neurological conditions and diseases, such as Alzheimer's disease, epilepsy and stroke.
Cancer-killing invention also harvests stem cells
Associate Professor Michael King of the University of Rochester Biomedical Engineering Department has invented a device that filters the blood for cancer and stem cells. When he captures cancer cells, he kills them. When he captures stem cells, he harvests them for later use in tissue engineering, bone marrow transplants, and other applications that treat human disease and improve health.